Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-16

Clinical Trial Update: Effect of Omega-3 Fatty Acid on Cortical Function in ADHD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the effect of omega-3 fatty acids on cortical function in ADHD has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Cincinnati | Conditions: Attention Deficit Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-03-16